Antiplatelet Agents Can Promote Two-Peaked Thrombin Generation in Platelet Rich Plasma: Mechanism and Possible Applications

Tarandovskiy, Ivan D.; Artemenko, Elena O.; Panteleev, Mikhail A.; Sinauridze, Elena I.; Ataullakhanov, Fazoil I.
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
Background: Thrombin generation assay is a convenient and widely used method for analysis of the blood coagulation system status. Thrombin generation curve (TGC) is usually bell-shaped with a single peak, but there are exceptions. In particular, TGC in platelet-rich plasma (PRP) can sometimes have two peaks. Objective: We sought to understand the mechanism underlying the occurrence of two peaks in the PRP thrombin generation curve. Methods: Tissue factor-induced thrombin generation in PRP and platelet-poor plasma (PPP) was monitored using continuous measurement of the hydrolysis rate of the thrombin-specific fluorogenic substrate Z-Gly-Gly-Arg-AMC. Expression of phosphatidylserine (PS) and CD62P on the surface of activated platelets was measured by flow cytometry using corresponding fluorescently labeled markers. Results: The addition of the P2Y12 receptor antagonist MeS-AMP (160 µM), 83 nM prostaglandin E1 (PGE1), or 1.6% DMSO to PRP caused the appearance of two peaks in the TGC. The PS exposure after thrombin activation on washed platelets in a suspension supplemented with DMSO, PGE1 or MeS-AMP was delayed, which could indicate mechanism of the second peak formation. Supplementation of PRP with 1.6% DMSO plus 830 nM PGE1 mediated the disappearance of the second peak and decreased the amplitude of the first peak. Increasing the platelet concentration in the PRP promoted the consolidation of the two peaks into one. Conclusions: Procoagulant tenase and prothrombinase complexes in PRP assemble on phospholipid surfaces containing PS of two types - plasma lipoproteins and the surface of activated platelets. Thrombin generation in the PRP can be two-peaked. The second peak appears in the presence of platelet antagonists as a result of delayed PS expression on platelets, which leads to delayed assembly of the membrane-dependent procoagulant complexes and a second wave of thrombin generation.


Related Articles

  • Phosphatidylserine and FVa regulate FXa structure. SRIVASATAVA, Kinshuk Raj; MAJUMDER, Rinku; KANE, William H.; QUINN-ALLEN, Mary Ann; LENTZ, Barry R. // Biochemical Journal;4/1/2014, Vol. 459 Issue 1, p229 

    Human coagulation FXa (Factor Xa) plays a key role in blood coagulation by activating prothrombin to thrombin on 'stimulated' platelet membranes in the presence of its cofactor FVa (Factor Va). PS (phosphatidylserine) exposure on activated platelet membranes promotes prothrombin activation by...

  • Lyso-Sulfatide Binds Factor Xa and Inhibits Thrombin Generation by the Prothrombinase Complex. Yegneswaran, Subramanian; Banerjee, Yajnavalka; Fernández, José A.; Deguchi, Hiroshi; Griffin, John H. // PLoS ONE;8/11/2015, Vol. 10 Issue 8, p1 

    Blood coagulation reactions are strongly influenced by phospholipids, but little is known about the influence of sphingolipids on coagulation mechanisms. Lysosulfatide (lyso-SF) (sulfogalactosyl sphingosine) prolonged factor Xa (fXa) 1-stage plasma clotting assays, showing it had robust...

  • Microparticles are new biomarkers of septic shock-induced disseminated intravascular coagulopathy. Delabranche, Xavier; Boisramé-Helms, Julie; Asfar, Pierre; Berger, Asaël; Mootien, Yoganaden; Lavigne, Thierry; Grunebaum, Lélia; Lanza, François; Gachet, Christian; Freyssinet, Jean-Marie; Toti, Florence; Meziani, Ferhat // Intensive Care Medicine;Oct2013, Vol. 39 Issue 10, p1695 

    Purpose: Septic shock-induced disseminated intravascular coagulopathy (DIC) contributes to multiple organ failure. Mechanisms governing vascular responses to open occurrence of DIC have not yet been established. Circulating plasma microparticles (MPs), released upon cell stress, constitute a...

  • Pleiotropic effects of factor Xa and thrombin: what to expect from novel anticoagulants. Spronk, Henri M.H.; de Jong, Anne Margreet; Crijns, Harry J.; Schotten, Ulrich; Van Gelder, Isabelle C.; ten Cate, Hugo // Cardiovascular Research;Mar2014, Vol. 101 Issue 3, p344 

    Factor Xa and thrombin are well-known components of the coagulation cascade and have been proven to be viable targets for effective anticoagulation treatment. However, accumulating evidence suggests that these serine proteases are also crucial modulators of other cellular mechanisms through the...

  • Identification of anti-prothrombin antibodies in the anti-phospholipid syndrome that display the prothrombinase activity. Yao-Hsu Yang; Chun-Jung Chang; Ya-Hui Chuang; Hui-Yao Hsu; Pojen P. Chen; Bor-Luen Chiang // Rheumatology;Jan2010, Vol. 49 Issue 1, p34 

    Objective. Prothrombin (PT) is one of the most important antigenic targets for aPL antibodies; however, the prothrombotic mechanism of anti-PT (aPT) antibodies in APS is not fully clarified. Considering that some autoantibodies possess the enzymatic activity, the aim of this study was to test...

  • Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban. Mueck, Wolfgang; Stampfuss, Jan; Kubitza, Dagmar; Becka, Michael // Clinical Pharmacokinetics;Jan2014, Vol. 53 Issue 1, p1 

    Rivaroxaban is an oral, direct Factor Xa inhibitor that targets free and clot-bound Factor Xa and Factor Xa in the prothrombinase complex. It is absorbed rapidly, with maximum plasma concentrations being reached 2-4 h after tablet intake. Oral bioavailability is high (80-100 %) for the 10 mg...

  • Evaluation of the association between FGBrs1800790 and plasma fibrinogen levels. Mashayekhi, A.; Shahbazi, Sh. // Scientific Journal of Iranian Blood Transfusion Organization;Spring2014, Vol. 11 Issue 1, p48 

    Background and Objectives Fibrinogen, coagulation factor 1, is a soluble plasma glycoprotein which converts thrombin to fibrin fibers in the coagulation cascade. Various polymorphisms located on beta chain gene, FGB, have been studied. The promoter - G455A (rs1800790) polymorphism had been shown...

  • Towards a standardization of thrombin generation assessment: The influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram-Thrombinoscope assay. Gerotziafas, Grigoris T.; Depasse, François; Busson, Joël; Leflem, Lena; Elalamy, Ismail; Samama, Meyer M. // Thrombosis Journal;2005, Vol. 3, p16 

    Background: Thrombin generation assay was developed several years ago to mimic physiological coagulation mechanisms but it had important limitations. Thrombogram-Thrombinoscope assay using a fluorogenic substrate, allows obtaining thrombin generation curves in non-defibrinated platelet rich...

  • Plasma Levels of Thrombin-Activatable Fibrinolysis Inhibitor in Primary and Secondary Thrombocytosis. Kaftan, O.; Balcik, O. S.; Cipil, H.; Ozet, G.; Bavbek, N.; Koşsar, A.; Dagdas, S. // Clinical & Applied Thrombosis/Hemostasis;Oct2005, Vol. 11 Issue 4, p449 

    An elevated platelet count is a common finding in both hospitalized and ambulatory patients. Thrombosis and bleeding complications are more frequently observed in patients with clonal thrombocytosis than secondary thrombocytosis. The aim of this study was to investigate the behaviors of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics